Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000035

President and CEO acquired 26,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-20 Grant or award : show line 1 in the form +26,500 676,189 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-20 Grant or award : show line 2 in the form Stock Option (right to buy) +107,800 107,800 D
Loading xslF345X03/edgar.xml…